41
Participants
Start Date
March 31, 2010
Primary Completion Date
May 31, 2010
Study Completion Date
florbetapir F 18
IV injection, 111 or 370MBq (3 or 10mCi), single dose
Lead Sponsor
Avid Radiopharmaceuticals
INDUSTRY